What Is a Consent Decree? How Companies Settle With Regulators Without Admitting Liability

A consent decree is a negotiated agreement between an enforcement agency and a defendant, entered as an order of a court, that resolves the case without an admission or adjudication of liability. The company promises specified conduct — compliance programs, reporting, remediation, sometimes payments — and the court retains power to enforce the decree through contempt. The signature phrase in nearly every corporate resolution is that the settlement is made "without admitting or denying the allegations," language the SEC formalized and the Department of Justice and environmental agencies mirror in their own decrees.

USA Post publishes information about enforcement practice, not legal advice.

How does a consent decree differ from an ordinary settlement?

An ordinary civil settlement is a contract: it ends the case, and a breach claim returns the parties to contract litigation. A consent decree is a court order. Because a federal judge enters it, violating it is contempt of court — a faster, harsher enforcement path than contract damages — and the decree's obligations run under continuing judicial supervision, sometimes for a decade. That structure explains both sides' incentives: the agency gets enforcement teeth without trial risk; the company avoids an admission and a litigated judgment but accepts a regime where future conduct is policed by a judge. Under Rule 65(d) of the Federal Rules of Civil Procedure, the decree binds parties and their officers and agents who receive actual notice.

What do corporate consent decrees typically require?

The standard architecture, visible across DOJ, EPA, CFPB and consent orders, has four layers. First, injunctive relief: the specific conduct changes — stop the practice, restructure the product, divest an asset. Second, compliance infrastructure: a written program, a designated compliance officer, training, and often an independent monitor reporting to the court or agency. Third, reporting and certification: periodic reports, certifications signed by senior executives, which create personal exposure if false. Fourth, payments: civil penalties, disgorgement, restitution or consumer redress, each carrying different tax and accounting treatment. Antitrust consent decrees add a distinctive feature — the Tunney Act, 15 U.S.C. 16, requires a 60-day public comment period and a judicial finding that the settlement is in the public interest before entry.

Why do companies insist on "no admission" language?

Because an admission is a loaded weapon in every other forum. A stipulated fact in an SEC or DOJ consent decree becomes exhibit A in follow-on private litigation, state attorney-general actions, insurance coverage disputes and foreign proceedings. The no-admission structure was tested and held meaningful in practice: under the SEC's own policy since 2013, defendants may settle without admitting unless they face a parallel criminal admission, and courts have upheld the practice over challenges that it renders judgments unreviewable. Criminal plea and deferred-prosecution agreements are different instruments: a DPA is a charging agreement with an admitted statement of facts; a civil consent decree with no-admission language concedes nothing but performance of the decree itself.

Can a consent decree be modified later?

Yes, under Rule 60(b)(5), but the Supreme Court's decision in Rufo v. Inmates of Suffolk County Jail (1992) sets a flexible standard: a movant must show a significant change in facts or law that makes compliance inequitable, or that the decree proved unworkable. Agostini v. Felton (1997) added that changes in the governing legal landscape can justify modification. Companies seeking relief from decade-old decrees — say, obsolete technology mandates — carry the burden, and courts weigh the public-interest purpose of the decree against changed circumstances. Modification is neither automatic nor rare: routine amendments adjust deadlines by consent, while substantive changes draw opposition from the agency and sometimes intervenors.

What should a company's board weigh before consenting?

1. Total cost, not just headline payments: monitors, consultants, reporting infrastructure and management attention typically exceed the penalty over the decree's life.
2. Executive certification exposure: who signs periodic compliance statements, and what diligence backs the signature.
3. Scope of release: which claims, entities, and individuals are released, and which state or foreign authorities remain free to act.
4. Exit mechanics: term length, conditions for early termination, and the modification standard if assumptions fail.
5. Collateral consequences: debarment, licensing, listing standards and insurance all read consent decrees as if they were admissions in practice.

What happens when a company breaches a decree?

The agency moves for contempt or to reopen the underlying case. Contempt requires proof that the decree was violated and that the violator had the ability to comply — the classic McComb v. Jacksonville Paper line of authority — and remedies range from coercive daily fines to compensatory payments and, in extreme recalcitrance, appointment of a receiver. The specter of that escalation is the decree's real engine: most compliance lapses are negotiated into stipulated remediation plans rather than litigated, because both sides prefer supervision to contempt.